Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Citations
10,501 citations
Cites background from "Highly prevalent TERT promoter muta..."
...In some (154;579), but not all (580) reports, TERT mutations were found more often in PTC carrying a BRAF mutation....
[...]
730 citations
613 citations
526 citations
447 citations
Cites background from "Highly prevalent TERT promoter muta..."
...Thyroid cancer (papillary and poorly differentiated carcinomas) 50–52 [105]...
[...]
References
52,293 citations
9,785 citations
"Highly prevalent TERT promoter muta..." refers background in this paper
...Melanomas and follicular cell-derived thyroid cancer share considerably similar genetic backgrounds; for example, they both harbor the BRAF V600E mutation with a high prevalence (Davies et al. 2002, Xing 2005a)....
[...]
1,602 citations
1,557 citations
"Highly prevalent TERT promoter muta..." refers background or result in this paper
...A germline AOC (TOG on opposite strand) mutation at K57 bp from the ATG translation start site of the TERT gene was found in familial melanomas (Horn et al. 2013), but we did not find this mutation in any of the thyroid tumor samples or cell lines in the present study....
[...]
...…extremely high in thyroid cancer cell lines (91.7%), which is in contrast to the low prevalence of 16% (24/150) in general cancer cell lines from the Cancer Cell Line Encyclopedia (Huang et al. 2013), but is similar to the high prevalence of 74% (125/168) in melanoma cell lines (Horn et al. 2013)....
[...]
...In fact, the two mutations have been demonstrated to confer increased transcriptional activity on the TERT promoter (Horn et al. 2013, Huang et al. 2013)....
[...]
...…cancer; MTC, medullary thyroid cancer. http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain UACC62) examined harbored the C250T mutation (data not shown), as found in other melanoma cell lines (Horn et al. 2013, Huang et al. 2013)....
[...]
...This resulted in a PCR product of 235 bp, containing the sites where mutations C228T and C250T occur in melanomas (Horn et al. 2013, Huang et al. 2013)....
[...]
1,426 citations
"Highly prevalent TERT promoter muta..." refers background in this paper
...R e la te d C a n ce r http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain 40–50 ng of genomic DNA were used in the PCR, which was carried out with an initial denaturation step at 95 8C for 3 min, followed by ten cycles of 95 8C denaturation for 30 s, 55 8C annealing for 30 s, and 68 8C elongation for 1 min....
[...]
...Follicular cell-derived thyroid cancer can be classified into several histological types (DeLellis et al. 2004), among which the most common types are papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), which account for 85–90% and 10–15% of all the thyroid cancers respectively (DeLellis et al. 2004, Jemal et al. 2011, http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain Howlader et al. 2012)....
[...]
...R e la te d C a n ce r http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain Published by Bioscientifica Ltd. Downloa Mutations 1 295 228 COT and 1 295 250 COT (termed C228T and C250T respectively), corresponding to K124 COT and K146 COT from the translation start site in the promoter of the telomerase reverse transcriptase (TERT ) gene, have recently been reported in human cancers, but not in thyroid cancers yet....
[...]
...(doi:10.1016/ j.molmed.2012.11.006) Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS et al. 2012 American Thyroid http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain Association Anaplastic Thyroid Cancer Guidelines Taskforce....
[...]
...Three melanoma cell lines (M14, A375, and PTC, papillary thyroid cancer; CPTC, conventional PTC; FVPTC, follicular variant PTC; TCPTC, tall-cell PTC; FTC, follicular thyroid cancer; DTC, differentiated thyroid cancer (combination of PTC and FTC); PDTC, poorly DTC; ATC, anaplastic thyroid cancer; MTC, medullary thyroid cancer. http://erc.endocrinology-journals.org q 2013 Society for Endocrinology DOI: 10.1530/ERC-13-0210 Printed in Great Britain UACC62) examined harbored the C250T mutation (data not shown), as found in other melanoma cell lines (Horn et al. 2013, Huang et al. 2013)....
[...]